Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Antibody / Recombinant Antibody

Anti-PELP1 Antibody (R4A64)

Catalog #:   RHN89303 Specific References (50) DATASHEET
Host species: Mouse
Isotype: IgG2a
Applications: ELISA, FCM
Accession: Q8IZL8
Overview

Catalog No.

RHN89303

Species reactivity

Human

Host species

Mouse

Isotype

IgG2a

Clonality

Monoclonal

Tested applications

ELISA: 1:10000, FCM: 1:200-1:400

Target

Modulator of non-genomic activity of estrogen receptor, Proline-, glutamic acid- and leucine-rich protein 1, HMX3, MNAR, Transcription factor HMX3, PELP1

Concentration

1 mg/ml

Endotoxin level

Please contact with the lab for this information.

Purity

>95% as determined by SDS-PAGE.

Purification

Protein A/G purified from cell culture supernatant.

Accession

Q8IZL8

Applications

ELISA, FCM

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4, 0.05% Sodium Azide.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.

Clone ID

R4A64

Data Image
  • Flow Cytometry
    Flow cytometric analysis of Hela cells using PELP1 mouse mAb (green) and negative control (red).
References

Sustained Clinical Benefit of AAV Gene Therapy in Severe Hemophilia B., PMID:40499172

Correlation analysis between the prevalence of common respiratory pathogens and exposure to ambient air pollutants in Central China, 2014-2022., PMID:40115343

Antimicrobial susceptibility and epidemiological types of Legionella pneumophila human isolates from Italy (1987-2020)., PMID:39824283

Liver-directed AAV gene therapy normalizes disease symptoms and provides cross-correction in a model of lysosomal acid lipase deficiency., PMID:39489913

Cholesterol as an inbuilt immunoadjuvant for a lipopeptide vaccine against group A Streptococcus infection., PMID:38387185

Antibody-Mediated Nanodrug of Proteasome Inhibitor Carfilzomib Boosts the Treatment of Multiple Myeloma., PMID:37801632

Neosporosis in Argentina: Past, present and future perspectives., PMID:37208088

[Strategy of the French Society of Childhood Cancer (SFCE) for pediatric nodular lymphocyte predominant lymphoma]., PMID:37062647

Selective modulation of activated protein C activities by a nonactive site-targeting nanobody library., PMID:36735416

Novel Synthetic Lipopeptides as Potential Mucosal Adjuvants Enhanced SARS-CoV-2 rRBD-Induced Immune Response., PMID:35356002

TNF-α response in macrophages depends on clinical Legionella pneumophila isolates genotypes., PMID:35030980

Daratumumab Immunopolymersome-Enabled Safe and CD38-Targeted Chemotherapy and Depletion of Multiple Myeloma., PMID:34369013

Targeted Mass Spectrometry-Based Approach for the Determination of Intrinsic Internalization Kinetics of Cell-Surface Membrane Protein Targets., PMID:34255494

Source attribution of community-acquired cases of Legionnaires' disease-results from the German LeTriWa study; Berlin, 2016-2019., PMID:33237924

Delayed-type hypersensitivity skin test against Neospora caninum in heifers with undetectable specific antibodies., PMID:32739729

Antibodies against atypical pathogens and respiratory viruses detected by Pneumoslide IgM test in adults with community-acquired pneumonia in Guangzhou City., PMID:32537759

Large community-acquired Legionnaires' disease outbreak caused by Legionella pneumophila serogroup 1, Italy, July to August 2018., PMID:32458793

Targeting CD38-Expressing Multiple Myeloma and Burkitt Lymphoma Cells In Vitro with Nanobody-Based Chimeric Antigen Receptors (Nb-CARs)., PMID:32013131

Immune response to Neospora caninum live tachyzoites in prepubertal female calves., PMID:31485864

Immunoglobulin M profile of viral and atypical pathogens among children with community acquired lower respiratory tract infections in Luzhou, China., PMID:31409320

Structure-activity relationship of group A streptococcus lipopeptide vaccine candidates in trimethyl chitosan-based self-adjuvanting delivery system., PMID:31247372

Anti-Multiple Myeloma Activity of Nanobody-Based Anti-CD38 Chimeric Antigen Receptor T Cells., PMID:30185037

Expression, purification and evaluation of recombinant lipoprotein of Salmonella typhi as a vaccine candidate., PMID:28189484

Lessons From an Outbreak of Legionnaires' Disease on a Hematology-Oncology Unit., PMID:27919312

Epidemiological Investigation of Legionella pneumophila Serogroup 2 to 14 Isolates from Water Samples by Amplified Fragment Length Polymorphism and Sequence-Based Typing and Detection of Virulence Traits., PMID:27496776

Isolation and molecular characterization of a new Neospora caninum isolate from cattle in Argentina., PMID:25913666

Molecular typing of Legionella pneumophila serogroup 1 clinical strains isolated in Italy., PMID:24881962

Targeted modifications in adeno-associated virus serotype 8 capsid improves its hepatic gene transfer efficiency in vivo., PMID:23442071

Infectious bursal disease virus rescued efficiently with 3' authentic RNA sequence induces humoral immunity without bursal atrophy., PMID:23196210

Identification of legionella in clinical samples., PMID:23150388

Adherence of platelets to in situ albumin-binding surfaces under flow conditions: role of surface-adsorbed albumin., PMID:22652380

Synthesis and purification of a toxin-linked conjugate targeting epidermal growth factor receptor in Escherichia coli., PMID:22381467

Inhibition of IGF-1 signalling enhances the apoptotic effect of AS602868, an IKK2 inhibitor, in multiple myeloma cell lines., PMID:21799925

Long-term safety and efficacy following systemic administration of a self-complementary AAV vector encoding human FIX pseudotyped with serotype 5 and 8 capsid proteins., PMID:21245849

Combined effect of olfactory ensheathing cell (OEC) transplantation and glial cell line-derived neurotrophic factor (GDNF) intravitreal injection on optic nerve injury in rats., PMID:21203408

Recombinant adeno-associated virus-mediated in utero gene transfer gives therapeutic transgene expression in the sheep., PMID:20919876

A preliminary assessment of the occupational risk of acquiring Legionnaires' disease for people working in telephone manholes, a new workplace environment for Legionella growth., PMID:20472324

Development of the dual-vector system-III (DVS-III), which facilitates affinity maturation of a Fab antibody via light chain shuffling., PMID:20471422

Vasoproliferative retinal tumours in a Swedish population., PMID:19860770

P-selectin glycoprotein ligand-1 as a potential target for humoral immunotherapy of multiple myeloma., PMID:19508173

Distribution of growth hormone-releasing hormone-like peptide: Immunoreactivity in the central nervous system of the adult zebrafish (Danio rerio)., PMID:19235874

Performance of AAV8 vectors expressing human factor IX from a hepatic-selective promoter following intravenous injection into rats., PMID:18312698

Multiple myeloma cells directly stimulate bone resorption in vitro by down-regulating mature osteoclast apoptosis., PMID:18282599

Blockade of natural killer cell-mediated lysis by NCAM140 expressed on tumor cells., PMID:17294447

Safe and efficient transduction of the liver after peripheral vein infusion of self-complementary AAV vector results in stable therapeutic expression of human FIX in nonhuman primates., PMID:17090654

Leptospira DNA detection for the diagnosis of human leptospirosis., PMID:16368457

Mechanisms of cell sensitization to alpha radioimmunotherapy by doxorubicin or paclitaxel in multiple myeloma cell lines., PMID:16203801

Myeloma cells can directly contribute to the pool of RANKL in bone bypassing the classic stromal and osteoblast pathway of osteoclast stimulation., PMID:15238139

Preliminary approach to find synthetic peptides from nodavirus capsid potentially protective against sea bass viral encephalopathy and retinopathy., PMID:12711276

Legionella pneumophila serogroup 1 antibody kinetics in patients with Legionnaires' disease: implications for serological diagnosis., PMID:12685878

Datasheet

Document Download

Anti-PELP1 Antibody (R4A64).pdf

 

$ 220
Product specifications
50 μg 220 100 μg 350

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Anti-PELP1 Antibody (R4A64) [RHN89303]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only